VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 166 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $11,378,664 | +60.8% | 2,013,807 | +17.0% | 0.00% | +50.0% |
Q1 2024 | $7,075,920 | -14.8% | 1,721,635 | -12.5% | 0.00% | 0.0% |
Q4 2023 | $8,305,054 | -11.2% | 1,967,985 | -9.1% | 0.00% | -33.3% |
Q3 2023 | $9,351,088 | -27.2% | 2,164,558 | +11.0% | 0.00% | -25.0% |
Q2 2023 | $12,846,763 | -32.0% | 1,949,383 | -30.0% | 0.00% | -33.3% |
Q1 2023 | $18,900,993 | +89529.1% | 2,783,690 | -2.5% | 0.01% | 0.0% |
Q4 2022 | $21,088 | -99.9% | 2,853,832 | +4.3% | 0.01% | -40.0% |
Q3 2022 | $27,021,000 | -7.5% | 2,734,976 | +2.1% | 0.01% | 0.0% |
Q2 2022 | $29,212,000 | +14.1% | 2,680,025 | +18.4% | 0.01% | +25.0% |
Q1 2022 | $25,597,000 | -19.8% | 2,263,159 | +11.3% | 0.01% | -20.0% |
Q4 2021 | $31,909,000 | -3.5% | 2,033,578 | +5.4% | 0.01% | -9.1% |
Q3 2021 | $33,078,000 | -21.8% | 1,929,882 | -1.9% | 0.01% | -15.4% |
Q2 2021 | $42,294,000 | +62.9% | 1,966,427 | +13.8% | 0.01% | +44.4% |
Q1 2021 | $25,960,000 | +27.3% | 1,728,361 | +11.3% | 0.01% | +28.6% |
Q4 2020 | $20,397,000 | +43.9% | 1,552,238 | +5.8% | 0.01% | +16.7% |
Q3 2020 | $14,177,000 | -13.5% | 1,467,665 | +2.4% | 0.01% | -14.3% |
Q2 2020 | $16,393,000 | +18.5% | 1,433,008 | +7.3% | 0.01% | 0.0% |
Q1 2020 | $13,831,000 | -29.6% | 1,335,345 | +11.5% | 0.01% | 0.0% |
Q4 2019 | $19,655,000 | +32.0% | 1,197,721 | +6.9% | 0.01% | +16.7% |
Q3 2019 | $14,886,000 | +9.2% | 1,120,916 | +15.9% | 0.01% | +20.0% |
Q2 2019 | $13,631,000 | -5.6% | 967,404 | +23.3% | 0.01% | -16.7% |
Q1 2019 | $14,438,000 | +4.1% | 784,618 | +47.8% | 0.01% | 0.0% |
Q4 2018 | $13,867,000 | +132.5% | 530,705 | +104.2% | 0.01% | +200.0% |
Q3 2018 | $5,965,000 | +2022.8% | 259,910 | +934.3% | 0.00% | – |
Q2 2016 | $281,000 | +33.8% | 25,128 | 0.0% | 0.00% | – |
Q1 2016 | $210,000 | -2.3% | 25,128 | +8.6% | 0.00% | – |
Q4 2015 | $215,000 | -10.0% | 23,128 | +9.0% | 0.00% | – |
Q3 2015 | $239,000 | +4.8% | 21,228 | +18.4% | 0.00% | – |
Q2 2015 | $228,000 | – | 17,928 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |